Monden M - Search Results

1

[A case of hepatic cystadenocarcinoma growing aggressively in a short time].

Okami J, Sakon M, Fujiwara Y, Yamada T, Hasuike Y, Kanai T, Gotoh M, Monden M, Fukuda H. Okami J, et al. Among authors: monden m. Nihon Shokakibyo Gakkai Zasshi. 1996 Oct;93(10):769-74. Nihon Shokakibyo Gakkai Zasshi. 1996. PMID: 8921714 Japanese. No abstract available.

2

[Anti-tumor effect of interferon for hepatocellular carcinoma-from the clinical consideration].

Nagano H, Sakon M, Monden M. Nagano H, et al. Among authors: monden m. Nihon Shokakibyo Gakkai Zasshi. 2007 May;104(5):654-9. Nihon Shokakibyo Gakkai Zasshi. 2007. PMID: 17485944 Japanese. No abstract available.

3

[Molecular biology-based surgery for the future progress of cancer treatment].

Fujiwara Y, Yamamoto H, Monden M. Fujiwara Y, et al. Among authors: monden m. Nihon Geka Gakkai Zasshi. 2002 Mar;103(3):278-83. Nihon Geka Gakkai Zasshi. 2002. PMID: 11968757 Review. Japanese.

4

[Development and research of the new therapy for hepatocellular carcinoma--combined interferon and 5-fluorouracil therapy].

Nagano H, Sakon M, Monden M. Nagano H, et al. Among authors: monden m. Nihon Rinsho. 2002 Nov;60(11):2237-44. Nihon Rinsho. 2002. PMID: 12440136 Review. Japanese.

5

[The relationship between postoperative prognosis and positivity of PIVKA-II in patients with hepatocellular carcinoma].

Sakon M, Monden M, Goto M, Kanai T, Umeshita K, Ukei T, Mori T. Sakon M, et al. Among authors: monden m. Nihon Geka Gakkai Zasshi. 1992 Aug;93(8):827-32. Nihon Geka Gakkai Zasshi. 1992. PMID: 1331743 Japanese.

6

Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesions.

Monden M, Sakon M, Gotoh M, Kanai T, Umeshita K, Wang KS, Sakurai M, Kuroda C, Okamura J, Mori T. Monden M, et al. Cancer Chemother Pharmacol. 1992;31 Suppl:S38-44. doi: 10.1007/BF00687103. Cancer Chemother Pharmacol. 1992. PMID: 1333907

7

Relationship between pathologic prognostic factors and abnormal levels of des-gamma-carboxy prothrombin and alpha-fetoprotein in hepatocellular carcinoma.

Sakon M, Monden M, Gotoh M, Kanai T, Umeshita K, Nakano Y, Mori T, Sakurai M, Wakasa K. Sakon M, et al. Among authors: monden m. Am J Surg. 1992 Feb;163(2):251-6. doi: 10.1016/0002-9610(92)90111-4. Am J Surg. 1992. PMID: 1371207

8

Interleukin-6 in bile as a marker of allograft rejection following liver transplantation in man.

Umeshita K, Monden M, Tono T, Hasuike Y, Kanai T, Gotoh M, Mori T, Seu P, Shaked A, Busuttil RW. Umeshita K, et al. Among authors: monden m. Transplant Proc. 1992 Aug;24(4):1462-4. Transplant Proc. 1992. PMID: 1496619 No abstract available.

9

[The clinical significance of PIVKA-II determination in patients with hepatocellular carcinoma: a comparative study with alpha-fetoprotein].

Sakon M, Monden M, Goto M, Kanai T, Umeshita K, Endo W, Mori T. Sakon M, et al. Among authors: monden m. Nihon Geka Gakkai Zasshi. 1990 May;91(5):588-93. Nihon Geka Gakkai Zasshi. 1990. PMID: 1696680 Japanese.

10

[The efficacy of intra-arterial infusion chemotherapy in patients with metastatic liver tumors].

Kanai T, Monden M, Gotoh M, Sakon M, Kobayashi K, Umeshita K, Ukei T, Shimano T, Monden T, Morimoto H, et al. Kanai T, et al. Among authors: monden m, monden t. Gan To Kagaku Ryoho. 1991 Aug;18(11):1982-6. Gan To Kagaku Ryoho. 1991. PMID: 1908663 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

904 results

Search Page

Filters